Xencor, Inc Prepaid Expense and Other Assets, Current
Xencor, Inc (XNCR) had Prepaid Expense and Other Assets, Current of $24.53 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-05
- 2026-06-30: Prepaid Expense and Other Assets, Current $24.53M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $25.90M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $22.79M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $25.59M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $24.53M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $25.90M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $22.79M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $25.59M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $21.73M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $13.92M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $18.98M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $20.75M 10-Q/A · filed 2025-02-24 | $20.15M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $24.59M 10-Q/A · filed 2025-02-24 | $23.99M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $16.73M 10-Q/A · filed 2025-02-24 | $16.74M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $18.14M 10-K · filed 2025-02-27 | $18.14M 10-K · filed 2024-02-29 |
| 2023-09-30 | $21.64M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $22.17M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $22.09M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $23.28M 10-K/A · filed 2025-02-24 | |
| 2022-09-30 | $22.89M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $19.73M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $23.01M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $23.88M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $20.88M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $15.59M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $14.16M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $10.73M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $10.19M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $7.40M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $6.48M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $6.55M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $7.53M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $11.31M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $9.43M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $10.38M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $12.10M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $12.07M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $6.65M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $5.61M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $7.03M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $7.62M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $4.37M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $2.90M 10-K · filed 2018-02-28 | |
| 2016-09-30 | $3.45M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $2.19M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $1.84M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $1.20M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $865.00K 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $711.00K 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $422.00K 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $134.00K 10-K · filed 2016-03-08 | |
| 2014-09-30 | $162.00K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $402.00K 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $159.00K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $60.00K 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |